Ilaris 150 MG/ML vialml
Ended Awarded
- Contract number
- SPE2DB25FX1VQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,828
Award facts
- Contract value 100% obligated
- $12,827.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,827.51 to DMS Pharmaceutical Group Inc. for the supply of ILARIS 150 mg/ml vials. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this work at its Park Ridge facility with an ultimate completion date of May 15, 2025. This delivery order was issued under a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities worldwide. ILARIS, a specialty pharmaceutical product, falls within the broader portfolio of branded and generic prescription drugs, biologics, and medical consumables that DMS Pharmaceutical Group supplies to Department of Defense healthcare sites as part of this critical federal pharmaceutical supply chain relationship.
Quick answers
Who was awarded contract SPE2DB25FX1VQ?
SPE2DB25FX1VQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FX1VQ worth?
The government has obligated $12,828 on SPE2DB25FX1VQ.
Is contract SPE2DB25FX1VQ an order under another contract?
Yes. SPE2DB25FX1VQ is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX1VQ competed?
The extent of competition for SPE2DB25FX1VQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award